Why One Korean Biotech Picked New Jersey for U.S. Headquarters

New Insights Into T Cell Exhaustion and Inflammation in Long COVID

Four tips for midsized companies when entering new global markets.

New Data Links Chronic Antigen Exposure to Immune Dysfunction in Post-Acute Syndromes

Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and evidence of T cell exhaustion in long COVID patients, providing deeper insight into post-infection immune disruption.

April 15th 2025

ABPI Restores Novo Nordisk’s Membership

Nigel McCracken, chief operating officer, Virax Biolabs, discusses results from new data on the role of T cell dysfunction in post-acute infection syndromes.

March 21st 2025

The Challenges of Market Access in Europe that Pharma Companies Face: Q&A with Mike Ryan

The pharmaceutical company had previously been subjected to a 2-year suspension.

March 20th 2025

The NIH’s Role in New Drug Development

Pharma companies face unique challenges with market access in this region.

March 7th 2025

Bringing Biotech Innovation Across Borders

Dr. Hernan Bazan, CEO of South Rampart Pharma, discusses his company’s current pipeline.

Related Content

Ed Ahn

New Insights Into T Cell Exhaustion and Inflammation in Long COVID

Four tips for midsized companies when entering new global markets.

New Data Links Chronic Antigen Exposure to Immune Dysfunction in Post-Acute Syndromes

April 15th 2025

ABPI Restores Novo Nordisk’s Membership

Nigel McCracken, chief operating officer, Virax Biolabs, discusses results from new data on the role of T cell dysfunction in post-acute infection syndromes.

March 21st 2025

The Challenges of Market Access in Europe that Pharma Companies Face: Q&A with Mike Ryan

The pharmaceutical company had previously been subjected to a 2-year suspension.

March 20th 2025

The NIH’s Role in New Drug Development

Pharma companies face unique challenges with market access in this region.